Velorum Therapeutics
Breakthrough medicines unlocking the biology of heme
San Francisco, United States · Founded 2023 · $500K raised
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2023
- Website
- velorumtx.com
- Total Funding
- $500K
- Last Round
- $500K Pre-SeedFeb 2024
- Rounds
- 1
About
Velorum Therapeutics is developing breakthrough medicines by unlocking the biology of heme.
Summary
Velorum Therapeutics is a Biotech company based in San Francisco, United States, founded in 2023. It has raised $500K in total across 1 round, most recently a $500K Pre-Seed round in Feb 2024. Investors include Y Combinator Continuity Fund, 468 Capital and Jaan Tallinn.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2024
Investors
Similar Companies
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...